Please turn JavaScript on

Journal of Urgent Care Medicine

Subscribe in seconds and receive Journal of Urgent Care Medicine's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.

You can select the updates using tags or topics and you can add as many websites to your feed as you like.

And the service is entirely free!

Follow Journal of Urgent Care Medicine: Journal Of Urgent Care Medicine

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.08 / day

Message History

The Food and Drug Administration (FDA) this month approved tebipenem pivoxil for adults with complicated urinary tract infections (cUTIs), including pyelonephritis, in patients who have limited or no alternative oral treatment options. Marketed as Utebzi, it is one of the more significant antibiotic approvals in recent years because it is the first oral carbapenem antibiotic...


Read full story

Cases of tetanus in the United States rose from 17 in 2020 to 38 in 2025, according to the latest data from the Centers for Disease Control and Prevention (CDC), prompting public health experts to suggest that Americans might check their vaccine status and consid...


Read full story

An AI model developed by researchers at New York-Presbyterian and Columbia University Irving Medical Center has received approval from the Food and Drug Administration for use in detecting structural heart disease through electrocardiograms (ECGs), according to a


Read full story

In an analysis of 3.4 million women under age 40, researchers in Japan found a strong association between menstrual-related disorders (ie, endometriosis or dysmenorrhea) and diagnosed sexually transmitted infections (STIs). Among the 257,897 women with these conditions, STI diagnoses were consistently 4.31–5.29 times more common than among women without the disorders, as pub...


Read full story

If approved, a new seasonal flu shot would become the first commercially available flu vaccine using mRNA technology, according to a news release. Moderna’s seasonal influenza vaccine mRNA-1010 (marketed as mFlusiva) has not yet r...


Read full story